GilbertPL, HarrisMJ, McAdamsLA, JesteDV. Neuroleptic withdrawal in schizophrenic patients. A review of the literature. Arch Gen Psychiatry, 52:173–188. 1995.
6.
GormanDA, ThompsonN, PlessenKJ, RobertsonMM, LeckmanJF, PetersonBS. Psychosocial outcome and psychiatric comorbidity in older adolescents with tourette syndrome: Controlled study. Br J Psychiatry, 1971:36–44. 2010.
7.
KaufmanJ, BirmaherB, BrentD, RaoU, RyanN. The schedule for affective disorders, schizophrenia for school-age children. Pittsburgh: University of Pittsburgh Medical Center, 1996.
8.
LeckmanJF, RiddleMA, HardinMT, OrtSI, SwartzKL, StevensonJ, CohenDJ. The Yale Global Tic Severity Scale: Initial Testing of a Clinician-Rated Scale of Tic Severity. J Am Acad Child Adolesc Psychiatry, 28:566–573. 1989.
9.
LinetLS. Tourette syndrome, pimozide, and school phobia: The neuroleptic separation anxiety syndrome. Am J Psychiatry, 142:613–615. 1985.
10.
MargoleseHC, AnnableL, DionY. Depression and dysphoria in adult and adolescent patients with tourette's disorder treated with risperidone. J Clin Psychiatry, 63:1040–1044. 2002.
11.
MejiaN, JankovicJ. Tardive dyskinsia and withdrawal emergent syndrome in children. Expert Rev Neurother, 10:893–901. 2010.
12.
MikkelsenEJ, DetlorJ, CohenDJ. School avoidance and social phobia triggered by haloperidol in patients with tourette's disorder. Am J Psychiatry, 138:1572–1576. 1981.
13.
MizrahiR, RusjanP, AgidO, GraffA, MamoDC, ZipurskyRB, KapurS. Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: A PET study in schizophrenia. Am J Psychiatry, 164:630–637. 2007.
